Health ❯ Obesity

Diabetes

Treatment Options Type 2 Diabetes Medications GLP-1 Drugs Treatment Methods Weight Loss Diet-Related Diseases Health Organizations Drug Development Genetics and Health Health Statistics Clinical Studies Prescription Medications Treatments Metabolic Disorders Dietary Impact Health Risks Medication Treatment Risk Factors Heart Failure Pharmaceutical Treatments China Market Treatment Solutions Treatment

Novo Nordisk Sues Lilly Over Weight‑Loss Ads as GLP‑1 Rivalry Intensifies

The case seeks to curb Eli Lilly’s consumer ads and could change how head‑to‑head trial results are shown to patients and prescribers.

Novo Nordisk Asks Court to Halt Lilly’s National GLP‑1 Ads

Five-Target ‘Trojan Horse’ Drug Outperforms Leading Incretins in Obese Diabetic Mice

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November

Lilly Steps Up Obesity Push With San Diego Innovation Hub and $6.5 Billion Houston Factory

Eli Lilly Halts Diabetes Arm of Bimagrumab Obesity Trial Weeks After Launch

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control